Zobrazeno 1 - 10
of 16
pro vyhledávání: '"GUILLERMO HOPPE ELSHOLZ"'
Autor:
Guillermo Hoppe-Elsholz, Alejandro Piña-Iturbe, Omar P. Vallejos, Isidora D. Suazo, Javiera Sepúlveda-Alfaro, Patricia Pereira-Sánchez, Yohana Martínez-Balboa, Eduardo A. Catalán, Pablo Reyes, Valentina Scaff, Franco Bassi, Sofia Campos-Gajardo, Andrea Avilés, Carlos A. Santiviago, Alexis M. Kalergis, Susan M. Bueno
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
Excisable genomic islands (EGIs) are horizontally acquired genetic elements that harbor an array of genes with diverse functions. ROD21 is an EGI found integrated in the chromosome of Salmonella enterica serovar Enteritidis (Salmonella ser. Enteritid
Externí odkaz:
https://doaj.org/article/92c1066d2e054c32bf6c83bc34ca1e16
Autor:
Alejandro Piña-Iturbe, Guillermo Hoppe-Elsholz, Paulina A. Fernández, Carlos A. Santiviago, Pablo A. González, Susan M. Bueno
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Genomic islands (GIs) are horizontally transferred elements that shape bacterial genomes and contributes to the adaptation to different environments. Some GIs encode an integrase and a recombination directionality factor (RDF), which are the
Externí odkaz:
https://doaj.org/article/9f4382846bf043bb880cf8f17fa1ec09
Autor:
Jorge A. Soto, Felipe Melo-González, Cristián Gutierrez-Vera, Bárbara M. Schultz, Roslye V. Berríos-Rojas, Daniela Rivera-Pérez, Alejandro Piña-Iturbe, Guillermo Hoppe-Elsholz, Luisa F. Duarte, Yaneisi Vázquez, Daniela Moreno-Tapia, Mariana Ríos, Pablo A. Palacios, Richard Garcia-Betancourt, Álvaro Santibañez, Gaspar A. Pacheco, Constanza Mendez, Catalina A. Andrade, Pedro H. Silva, Benjamín Diethelm-Varela, Patricio Astudillo, Mario Calvo, Antonio Cárdenas, Marcela González, Macarena Goldsack, Valentina Gutiérrez, Marcela Potin, Andrea Schilling, Lorena I. Tapia, Loreto Twele, Rodolfo Villena, Alba Grifoni, Alessandro Sette, Daniela Weiskopf, Rodrigo A. Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Mónica L. Acevedo, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Angello Retamal-Díaz, Nathalia Muñoz-Jofré, Xing Meng, Qianqian Xin, Eduardo Alarcón-Bustamante, José V. González-Aramundiz, Nicole Le Corre, María Javiera Álvarez-Figueroa, Pablo A. González, Katia Abarca, Cecilia Perret, Leandro J. Carreño, Susan M. Bueno, Alexis M. Kalergis
Publikováno v:
mBio, Vol 13, Iss 6 (2022)
ABSTRACT Multiple vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been evaluated in clinical trials. However, trials addressing the immune response in the pediatric population are scarce. The inactivated vaccine Cor
Externí odkaz:
https://doaj.org/article/cf113e0121754f51995644752d348004
Autor:
Nicolás MS Gálvez, Gaspar A Pacheco, Bárbara M Schultz, Felipe Melo-González, Jorge A Soto, Luisa F Duarte, Liliana A González, Daniela Rivera-Pérez, Mariana Ríos, Roslye V Berrios, Yaneisi Vázquez, Daniela Moreno-Tapia, Omar P Vallejos, Catalina A Andrade, Guillermo Hoppe-Elsholz, Carolina Iturriaga, Marcela Urzua, María S Navarrete, Álvaro Rojas, Rodrigo Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Mónica L Acevedo, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Daniela Weiskopf, Alba Grifoni, Alessandro Sette, Gang Zeng, Weining Meng, CoronaVacCL03 Study Group, José V González-Aramundiz, Marina Johnson, David Goldblatt, Pablo A González, Katia Abarca, Susan M Bueno, Alexis M Kalergis
Publikováno v:
eLife, Vol 11 (2022)
Background: The development of vaccines to control the coronavirus disease 2019 (COVID-19) pandemic progression is a worldwide priority. CoronaVac is an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine approved for eme
Externí odkaz:
https://doaj.org/article/ac762f639ff7488791e3508152fce059
Autor:
Bárbara M. Schultz, Felipe Melo-González, Luisa F. Duarte, Nicolás M. S. Gálvez, Gaspar A. Pacheco, Jorge A. Soto, Roslye V. Berríos-Rojas, Liliana A. González, Daniela Moreno-Tapia, Daniela Rivera-Pérez, Mariana Ríos, Yaneisi Vázquez, Guillermo Hoppe-Elsholz, Catalina A. Andrade-Parra, Omar P. Vallejos, Alejandro Piña-Iturbe, Carolina Iturriaga, Marcela Urzua, María S. Navarrete, Álvaro Rojas, Rodrigo Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Mónica L. Acevedo, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Daniela Weiskopf, Alba Grifoni, Alessandro Sette, Gang Zeng, Weining Meng, José V. González-Aramundiz, Pablo A. González, Katia Abarca, Alexis M. Kalergis, Susan M. Bueno
Publikováno v:
mBio, Vol 13, Iss 4 (2022)
ABSTRACT CoronaVac is an inactivated SARS-CoV-2 vaccine approved by the World Health Organization (WHO). Previous studies reported increased levels of neutralizing antibodies and specific T cells 2 and 4 weeks after two doses of CoronaVac; these leve
Externí odkaz:
https://doaj.org/article/0d12c0aeee20419bb5fc3ab69b554f1b
Autor:
Felipe Melo-González, Jorge A. Soto, Liliana A. González, Jorge Fernández, Luisa F. Duarte, Bárbara M. Schultz, Nicolás M. S. Gálvez, Gaspar A. Pacheco, Mariana Ríos, Yaneisi Vázquez, Daniela Rivera-Pérez, Daniela Moreno-Tapia, Carolina Iturriaga, Omar P. Vallejos, Roslye V. Berríos-Rojas, Guillermo Hoppe-Elsholz, Marcela Urzúa, Nicole Bruneau, Rodrigo A. Fasce, Judith Mora, Alba Grifoni, Alessandro Sette, Daniela Weiskopf, Gang Zeng, Weining Meng, José V. González-Aramundiz, Pablo A. González, Katia Abarca, Eugenio Ramírez, Alexis M. Kalergis, Susan M. Bueno
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible of the current pandemic ongoing all around the world. Since its discovery in 2019, several circulating variants have emerged and some of them are associat
Externí odkaz:
https://doaj.org/article/13f78279cb1a4b92aeac29dc13bff0ae
Autor:
Luisa F. Duarte, Nicolás M. S. Gálvez, Carolina Iturriaga, Felipe Melo-González, Jorge A. Soto, Bárbara M. Schultz, Marcela Urzúa, Liliana A. González, Yaneisi Vázquez, Mariana Ríos, Roslye V. Berríos-Rojas, Daniela Rivera-Pérez, Daniela Moreno-Tapia, Gaspar A. Pacheco, Omar P. Vallejos, Guillermo Hoppe-Elsholz, María S. Navarrete, Álvaro Rojas, Rodrigo A. Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Gang Zeng, Weining Meng, José V. González-Aramundiz, Pablo A. González, Katia Abarca, Susan M. Bueno, Alexis M. Kalergis
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Constant efforts to prevent infections by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are actively carried out around the world. Several vaccines are currently approved for emergency use in the population, while ongoing studies conti
Externí odkaz:
https://doaj.org/article/4e8fbbc37cb647b0bcc16a6cfa23cc35
Autor:
Bárbara M, Schultz, Felipe, Melo-González, Luisa F, Duarte, Nicolás Ms, Gálvez, Gaspar A, Pacheco, Jorge A, Soto, Roslye V, Berríos-Rojas, Liliana A, González, Daniela, Moreno-Tapia, Daniela, Rivera-Pérez, Mariana, Ríos, Yaneisi, Vázquez, Guillermo, Hoppe-Elsholz, Omar P, Vallejos, Carolina, Iturriaga, Marcela, Urzua, María S, Navarrete, Álvaro, Rojas, Rodrigo, Fasce, Jorge, Fernández, Judith, Mora, Eugenio, Ramírez, Aracelly, Gaete-Argel, Mónica, Acevedo, Fernando, Valiente-Echeverría, Ricardo, Soto-Rifo, Daniela, Weiskopf, Alba, Grifoni, Alessandro, Sette, Gang, Zeng, Weining, Meng, José V, González-Aramundiz, Pablo A, González, Katia, Abarca, Alexis M, Kalergis, Susan M, Bueno
Publikováno v:
medRxiv : the preprint server for health sciences.
BackgroundCoronaVac®is an inactivated SARS-CoV-2 vaccine approved by the World Health Organization. Previous studies reported increased levels of neutralizing antibodies and specific T cells two- and four-weeks after two doses of CoronaVac®, but th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e5dcd784221a536d2fd34dfe24d2529
https://pubmed.ncbi.nlm.nih.gov/35946814
https://pubmed.ncbi.nlm.nih.gov/35946814
Autor:
Roslye Berrios, Cristian Gutierrez-Vera, Bárbara M. Schultz, Patricio Andres Astudillo Paredes, GUILLERMO HOPPE ELSHOLZ, Luisa Fernanda Duarte Peñaloza, Andrea Schilling Redlich, Jorge Soto, Richard Garcia, Felipe Melo-Gonzalez, Fernando Valiente-Echeverria
BackgroundMultiple vaccines against SARS-CoV-2 have been evaluated in clinical trials, but very few include the pediatric population. The inactivated vaccine CoronaVac® has shown to be safe and immunogenic in a phase 1/2 clinical trial in a pediatri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17d3c1de18a9519ff852cfacd1ca94e9
https://doi.org/10.1101/2022.02.15.22270973
https://doi.org/10.1101/2022.02.15.22270973
Autor:
Alejandro Piña-Iturbe, Guillermo Hoppe-Elsholz, Paulina A. Fernández, Carlos A. Santiviago, Pablo A. González, Susan M. Bueno
Publikováno v:
Scientific reports. 12(1)
Genomic islands (GIs) are horizontally transferred elements that shape bacterial genomes and contributes to the adaptation to different environments. Some GIs encode an integrase and a recombination directionality factor (RDF), which are the molecula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d73b51d0f3d7626f5b7d7db5f5a79a1
https://pubmed.ncbi.nlm.nih.gov/35165310
https://pubmed.ncbi.nlm.nih.gov/35165310